Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells.
The Schwannian stroma in neuroblastomas is related to patient prognosis. There is debate surrounding the origin of Schwannian stroma in neuroblastomas: one theory is that the Schwann cells are derived from neoplastic cells, and the other is that they arise from normal cells surrounding the neuroblastoma. We examined whether human bone marrow stromal cells (hBMSCs) or human mesenchymal stem cells (hMSCs) could differentiate into Schwann cells in neuroblastomas. hBMSCs or hMSCs along with enhanced green fluorescent protein (EGFP) were injected into xenotransplanted neuroblastomas in nonobese diabetic mice with severe combined immunodeficiency and the resulting tumors were analyzed using immunohistochemistry. HBMSCs and hMSCs were co-cultured with neuroblastoma cells, and the induction of Schwann cell-specific molecules, S100beta and Egr-2, was monitored. S100beta-positive Schwannian stroma was observed only in neuroblastomas containing either hBMSCs or hMSCs, but not in neuroblastomas lacking these cells. Double staining with anti-S100 and anti-EGFP antibodies showed that S100-positive cells in neuroblastomas were also EGFP-positive. By contrast, hBMSCs did not develop into Schwann cells in Ewing's sarcoma, demonstrating that differentiation of transplanted hBMSCs or hMSCs into Schwann cells occurs specifically in neuroblastomas. Both S100beta and Egr-2 were expressed in hBMSCs or hMSCs co-cultured with neuroblastoma cells. HBMSCs or hMSCs may contribute to the formation of human tumor stroma. The Schwannian stroma of neuroblastomas appears to be derived from nonneoplastic stromal cells rather than neuroblastoma cells, further clarifying its developmental origins.
Du
Wenlin
W
Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Hozumi
Nobumichi
N
Sakamoto
Michiie
M
Hata
Jun-ichi
J
Yamada
Taketo
T
D000818:Animals; D001808:Blood Vessels / Q000473:pathology; D001854:Bone Marrow Cells / Q000473:pathology*; D002454:Cell Differentiation; D002460:Cell Line; D018920:Coculture Techniques; D051767:Early Growth Response Protein 2 / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000473:pathology; D051379:Mice; D016688:Mice, Inbred NOD; D009368:Neoplasm Transplantation; D009414:Nerve Growth Factors / Q000378:metabolism; D009447:Neuroblastoma / Q000473:pathology*; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000378:metabolism; D012583:Schwann Cells / Q000473:pathology*; D017154:Stromal Cells / Q000473:pathology*
D051767:Early Growth Response Protein 2; D009414:Nerve Growth Factors; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins; C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins
Am J Pathol. 2005 Mar;166(3):891-900
15743800
Microsurgery. 1998;18(7):397-405
9880154
Clin Neuropathol. 1994 Jul-Aug;13(4):171-80
7955661
Acta Neuropathol. 1989;79(2):217-21
2480694
Cancer. 1999 Jul 15;86(2):349-63
10421272
Nature. 1999 Oct 14;401(6754):670-7
10537105
J Cutan Pathol. 2002 Aug;29(7):397-406
12139634
Mol Cancer Ther. 2006 Mar;5(3):755-66
16546991
Dev Biol. 2002 Jun 15;246(2):245-58
12051814
Br J Haematol. 2007 Jun;137(6):491-502
17539772
Eur J Cancer. 1995;31A(4):429-34
7576940
J Neurosci Res. 1997 Dec 1;50(5):702-12
9418958
Science. 2000 Aug 18;289(5482):1197-202
10947988
Clin Cancer Res. 2005 Nov 1;11(21):7749-56
16278396
Cell Growth Differ. 1991 Oct;2(10):487-93
1751405
Nature. 2001 May 17;411(6835):375-9
11357145
J Exp Med. 2006 May 15;203(5):1235-47
16636132
Gene Ther. 2004 Jul;11(14):1155-64
15141157
Cancer Res. 2004 Dec 1;64(23):8492-5
15574751
Brain Res. 1987 Nov 24;426(2):349-57
2446713
Cancer Res. 2005 Apr 15;65(8):3193-9
15833850
Prog Brain Res. 2001;132:3-11
11544997
Oncogene. 2001 Apr 12;20(16):1981-9
11360182
N Engl J Med. 1996 Jun 6;334(23):1505-11
8618605
Cancer. 2002 Mar 1;94(5):1574-83
11920516
Med Pediatr Oncol. 2001 Jan;36(1):163-8
11464875
Int J Dev Biol. 2002;46(4):559-67
12141444
Oral Oncol. 2004 Nov;40(10):1048-56
15509497
Cancer Res. 2001 Sep 15;61(18):6892-8
11559566
Eur J Biochem. 2000 Dec;267(24):6972-5
11106405
Cancer Res. 2005 Apr 15;65(8):3307-18
15833864
Cancer Res. 2002 Jul 1;62(13):3603-8
12097260
Nat Med. 2001 Nov;7(11):1194-201
11689883
Science. 2004 Feb 6;303(5659):848-51
14764882
Glia. 2002 Mar 1;37(3):206-18
11857679
Br J Cancer. 2002 Apr 8;86(7):1110-6
11953858
Glia. 2001 Aug;35(2):81-9
11460264
Science. 1999 Apr 2;284(5411):143-7
10102814
J Invest Dermatol. 2005 Mar;124(3):638-43
15737206
Exp Cell Res. 2005 Jun 10;306(2):330-5
15925588
Cancer. 1999 Jul 15;86(2):364-72
10421273
Clin Exp Metastasis. 1999 Jun;17(4):333-40
10545020